Top compounds associated with response to LILRA5


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.23 3e-10
mRNA ATRA CTRPv2 pan-cancer AAC 0.21 1e-09
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 8e-08
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.22 7e-07
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA staurosporine CTRPv2 pan-cancer AAC 0.3 2e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA BRD-K30748066 CTRPv2 pan-cancer AAC 0.4 0.0001
mRNA AM-580 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV